GDP (gemcitabine, dexamethasone, cisplatin) salvage therapy results in superior progression free survival compared to mini-beam prior to autologous stem cell transplantation for relapsed or refractory Hodgkin's lymphoma.

被引：1
|
作者：
Kuruvilla, J [1 ]
Nagy, T [1 ]
Pintilie, M [1 ]
Keating, A [1 ]
Crump, M [1 ]
机构：
[1] Univ Toronto, Princess Margaret Hosp, Blood & Marrow Transplant Program, Toronto, ON, Canada
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.905.905
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
905
引用
收藏
页码：258A / 259A
页数：2
相关论文
共 50 条
  • [21] Positron emission tomography response at the time of autologous stem cell transplantation predicts outcome of patients with relapsed and/or refractory Hodgkin's lymphoma responding to prior salvage therapy
    Devillier, Raynier
    Coso, Diane
    Castagna, Luca
    Rossi, Isabelle Brenot
    Anastasia, Antonella
    Chiti, Arturo
    Ivanov, Vadim
    Schiano, Jean Marc
    Santoro, Armando
    Chabannon, Christian
    Balzarotti, Monica
    Blaise, Didier
    Bouabdallah, Reda
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (07): : 1073 - 1079
  • [22] Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma
    Majhail, Navneet S.
    Weisdorf, Daniel J.
    Defor, Todd E.
    Miller, Jeffrey S.
    McGlave, Philip R.
    Slungaard, Arne
    Arora, Mukta
    Ramsay, Norma K. C.
    Orchard, Paul J.
    MacMillan, Margaret L.
    Burns, Linda J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (10) : 1065 - 1072
  • [23] 18FDG-PET-NEGATIVE COMPLETE REMISSION PRIOR TO AUTOLOGOUS STEM CELL TRANSPLANTATION PREDICTS FOR SUPERIOR EVENT FREE SURVIVAL OF PATIENTS WITH RELAPSED OR REFRACTORY HODGKIN LYMPHOMA
    Peinert, S.
    Hoyt, R.
    Grigg, A.
    Prince, H. M.
    Seymour, J. F.
    Rigacci, L.
    Roberts, A.
    Szer, J.
    Ritchie, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 34 - 34
  • [24] Complete Remission on 18F-FDG-PET Prior to Autologous Stem Cell Transplantation Predicts Superior Event Free Survival of Patients with Relapsed or Refractory Hodgkin Lymphoma
    Peinert, Stefan
    Hoyt, Rosemary
    Szer, Jeffrey
    Seymour, John F.
    Prince, H. Miles
    Roberts, Andrew W.
    Rigacci, Luigi
    Grigg, Andrew
    Ritchie, David S.
    BLOOD, 2008, 112 (11) : 763 - 764
  • [25] High-dose therapy and autologous stem cell transplantation (HDT/ASCT) in relapsed/refractory Hodgkin's lymphoma. Outcome and prognostic factors
    Angelopoulou, M. K.
    Vassilakopoulos, T. P.
    Tsirkinidis, P.
    Tsopra, O.
    Galani, Z.
    Pappi, V.
    Moschogiannis, M.
    Dimitriadou, E.
    Anargyroy, K.
    Kalpadakis, C.
    Masouridis, S.
    Boutsis, D.
    Sachanas, S.
    Dimopoulou, M.
    Variamis, E.
    Vyniou, N. -A.
    Kokoris, S.
    Siakantaris, M. P.
    Kyrtsonis, M. -C.
    Panayiotidis, P.
    Rombos, Y.
    Pamgalis, G. A.
    Beris, P.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S255 - S255
  • [26] IPHOSPHAMIDE, GEMCITABINE, VINORELBINE (IGEV) CHEMOTHERAPY PLUS AUTOLOGOUS STEM CELL TRANSPLANTATION AS SALVAGE TREATMENT OF RELAPSED/REFRACTORY HODGKIN LYMPHOMA PEDIATRIC PATIENTS
    Sau, A.
    La Barba, G.
    Cecinati, V.
    Onofrillo, D.
    Falorio, S.
    Fioritoni, G.
    Angrilli, F.
    HAEMATOLOGICA, 2012, 97 : 566 - 566
  • [27] Gemcitabine, Dexamethasone, and Cisplatin (GDP) Is An Effective and Well-Tolerated out-Patient Salvage Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) and Hodgkin Lymphoma (HL)
    Moccia, Alden A.
    Hitz, Felicitas
    Hoskins, Paul
    Klasa, Richard
    Power, Maryse
    Savage, Kerry J.
    Shenkier, Tamara
    Shepherd, John
    Skinnider, Brian
    Slack, Graham W.
    Song, Kevin
    Gascoyne, Randy D.
    Connors, Joseph M.
    Sehn, Laurie
    BLOOD, 2010, 116 (21) : 56 - 56
  • [28] Ifosfamide salvage treatment before autologous stem cell transplantation in patients with refractory and relapsed Hodgkin's lymphoma:: a GELA experience
    Gisselbrecht, C
    Mounier, N
    Fermé, C
    Brice, P
    ANNALS OF ONCOLOGY, 2003, 14 : 39 - 41
  • [29] Salvage chemotherapy of gemcitabine, dexamethasone, and cisplatin (GDP) for patients with relapsed or refractory peripheral T-cell lymphomas: a consortium for improving survival of lymphoma (CISL) trial
    Park, Byeong-Bae
    Kim, Won Seog
    Suh, Cheolwon
    Shin, Dong-Yeop
    Kim, Jeong-A
    Kim, Hoon-Gu
    Lee, Won Sik
    ANNALS OF HEMATOLOGY, 2015, 94 (11) : 1845 - 1851
  • [30] Novel regimens prior to autologous stem cell transplantation for the management of adults with relapsed/refractory non-Hodgkin lymphoma and Hodgkin lymphoma: alternatives to BEAM conditioning
    Isidori, Alessandro
    Christofides, Anna
    Visani, Giuseppe
    LEUKEMIA & LYMPHOMA, 2016, 57 (11) : 2499 - 2509
12345